The rising cost of medication development has put pressure on R&D organizations to contribute to greater efficiency in developing novel drugs. In recent years, the pharmaceutical industry has made tremendous efforts to solve these issues and improve the efficiency of the drug development process. Indubitably, some of the initiatives have resulted in significant advances. Early evaluation of a drug’s toxicological profile and early studies to determine whether a new drug candidate is suitable for oral delivery or once-daily dosing are two examples. It is no longer a question of how skilled we are at what we do but rather whether we are doing the right things. Furth...
